In the quickly evolving area of most cancers therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is essential for developing powerful treatment plans. The most promising strategies is the use of in vitro bystander outcome assays, which Perform a pivotal position in boosting therapeutic efficacy. These assay